About Kaken TOP
Pharmaceuticals and Medical Devices
Agrochemicals and Animal Health Products
Research & Development Division
Investor Relations TOP
Consolidated Earnings Briefing
Consolidated Financial Results
December 13, 2021
Kaken Completes Acquisition of ARTham Therapeutics Inc.
November 30, 2021
Notice on Acquisition of ARTham Therapeutics Inc.
October 21, 2021
Achievement of the primary endpoint from the Phase III study in Japan of KMW-1 – Presented at the 47th Annual Meeting of the Japanese Society for Burn Injuries –
October 14, 2021
Achievement of Primary Endpoints from U.S. Phase 3 Pivotal Clinical Studies of BBI-4000 for Treatment of Primary Axillary Hyperhidrosis